| 1 |
Hashimoto T, Matsumoto S, Ando M, et al. Cerebral hyperperfusion syndrome after endovascular reperfusion therapy in a patient with acute internal carotid artery and middle cerebral artery occlusions [J]. World Neurosurg, 2018, 110: 145-151.
|
| 2 |
中国卒中学会科学声明专家组. 症状性颅内外动脉粥样硬化性大动脉狭窄管理规范——中国卒中学会科学声明 [J]. 中国卒中杂志, 2017, 12(1): 64-71.
|
| 3 |
许伟, 王春霞, 段新滨, 等. 替罗非班在大动脉粥样硬化型脑梗死治疗中的应用 [J]. 世界最新医学信息文摘, 2018, 18(66): 124.
|
| 4 |
Kikuchi T, Ishii A, Nakahara I, et al. Japanese registry of neuroendovascular therapy: extracranial steno-occlusive diseases except for internal carotid artery stenosis [J]. Neurol Med Chir (Tokyo), 2014, 54(1): 40-45.
|
| 5 |
Nicosia A, Nikas D, Castriota F, et al. Classification for carotid artery stenting complications: manifestation, management, and prevention [J]. Endovasc Ther, 2010, 17(3): 275-294.
|
| 6 |
Lieb M, Shah U, Hines GL. Cerebral hyperperfusion syndrome after carotid intervention: a review [J]. Cardiol Rev, 2012, 20(2): 84-89.
|
| 7 |
Lin YH, Liu HM. Update on cerebral hyperperfusion syndrome [J]. Neurointerv Surg, 2020, 12(8):788-793.
|
| 8 |
Meyers PM, Higashida RT, Phatouros CC, et al. Cerebral hyperperfusion syndrome after percutaneous transluminal stenting of the craniocervical arteries [J]. Neurosurgery, 2000, 47(2): 335-345.
|
| 9 |
Abou-Chebl A, Yadav JS, Reginelli JP, et al. Intracranial hemorrhage and hyperperfusion syndrome following carotid artery stenting: risk factors, prevention, and treatment [J]. Am Coll Cardiol, 2004, 43: 1596-1601.
|
| 10 |
González García A, Moniche F, Escudero-Martínez I, et al. Clinical predictors of hyperperfusion syndrome following carotid stenting: results from a national prospective multicenter study [J]. JACC Cardiovasc Interv, 2019, 12(9): 873-882.
|
| 11 |
Farooq MU, Goshgarian C, Min J, et al. Pathophysiology and management of reperfusion injury and hyperperfusion syndrome after carotid endarterectomy and carotid artery stenting [J]. Exp Transl Stroke Med, 2016, 8(1): 7.
|
| 12 |
Dohare P, Varma S, Ray M. Curcuma oil modulates the nitric oxide system response to cerebral ischemia/reperfusion injury [J]. Nitric Oxide, 2008, 19(1): 1-11.
|
| 13 |
Katsumata M, Tsuruta W, Hosoo H, et al. Suspected cerebral hyperperfusion syndrome after stenting for intracranial vertebral artery stenosis associated with reduced cerebral blood flow to the posterior cerebral artery territory [J]. Neuroendovasc Ther, 2021, 15(7): 460-466.
|
| 14 |
Zhang R, Zhou G, Xu G, et al. Posterior circulation hyperperfusion syndrome after bilateral vertebral artery intracranial stenting [J]. Ann Vasc Surg, 2009, 23(5): 686.e1-686.
|
| 15 |
Ryu CW, Koh JS, Yu SY, et al. Vasogenic edema of the basal ganglia after intra-arterial administration of nimodipine for treatment of vasospasm [J]. Korean Neurosurg Soc, 2011, 49(2): 112-115.
|
| 16 |
Zhang JH, Obenaus A, Liebeskind DS, et al. Recanalization, reperfusion, and recirculation in stroke [J]. Cereb Blood Flow Metab, 2017, 37(12): 3818-3823.
|
| 17 |
Manojlovic V, Budakov N, Budinski S, et al. Cerebrovacular reserve predicts the cerebral hyperperfusion syndrome after carotid endarterectomy [J]. Stroke Cerebrovasc Dis, 2020, 29(12): 105318.
|
| 18 |
Naylor AR. Medical treatment strategies to reduce perioperative morbidity and mortality after carotid surgery [J]. Semin Vasc Surg, 2017, 30(1): 17-24.
|
| 19 |
Delgado MG, Bogousslavsky J. Cerebral hyperperfusion syndrome and related conditions [J]. Eur Neurol, 2020, 83(5): 453-457.
|